214 related articles for article (PubMed ID: 11063386)
21. Tumor necrosis factor-α induces matrix metalloproteinases-3, -10, and -13 in human periodontal ligament cells.
Ahn SJ; Rhim EM; Kim JY; Kim KH; Lee HW; Kim EC; Park SH
J Periodontol; 2014 Mar; 85(3):490-7. PubMed ID: 23688099
[TBL] [Abstract][Full Text] [Related]
22. Vascular endothelial growth factor production in peritoneal macrophages of cirrhotic patients: regulation by cytokines and bacterial lipopolysaccharide.
Pérez-Ruiz M; Ros J; Morales-Ruiz M; Navasa M; Colmenero J; Ruiz-del-Arbol L; Cejudo P; Clária J; Rivera F; Arroyo V; Rodés J; Jiménez W
Hepatology; 1999 Apr; 29(4):1057-63. PubMed ID: 10094946
[TBL] [Abstract][Full Text] [Related]
23. Parathyroid-induced angiogenesis is VEGF-dependent.
Carter WB; Uy K; Ward MD; Hoying JB
Surgery; 2000 Sep; 128(3):458-64. PubMed ID: 10965318
[TBL] [Abstract][Full Text] [Related]
24. Induction of VEGF gene expression by retinoic acid through Sp1-binding sites in retinoblastoma Y79 cells.
Akiyama H; Tanaka T; Maeno T; Kanai H; Kimura Y; Kishi S; Kurabayashi M
Invest Ophthalmol Vis Sci; 2002 May; 43(5):1367-74. PubMed ID: 11980848
[TBL] [Abstract][Full Text] [Related]
25. Roxithromycin inhibits angiogenesis of human hepatoma cells in vivo by suppressing VEGF production.
Aoki D; Ueno S; Kubo F; Oyama T; Sakuta T; Matsushita K; Maruyama I; Aikou T
Anticancer Res; 2005; 25(1A):133-8. PubMed ID: 15816530
[TBL] [Abstract][Full Text] [Related]
26. Roxithromycin suppresses involucrin expression by modulation of activator protein-1 and nuclear factor-kappaB activities of keratinocytes.
Takahashi H; Hashimoto Y; Ishida-Yamamoto A; Iizuka H
J Dermatol Sci; 2005 Sep; 39(3):175-82. PubMed ID: 16140218
[TBL] [Abstract][Full Text] [Related]
27. Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma.
Cornali E; Zietz C; Benelli R; Weninger W; Masiello L; Breier G; Tschachler E; Albini A; Stürzl M
Am J Pathol; 1996 Dec; 149(6):1851-69. PubMed ID: 8952523
[TBL] [Abstract][Full Text] [Related]
28. Prostaglandin E2 induces vascular endothelial growth factor and basic fibroblast growth factor mRNA expression in cultured rat Müller cells.
Cheng T; Cao W; Wen R; Steinberg RH; LaVail MM
Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):581-91. PubMed ID: 9501870
[TBL] [Abstract][Full Text] [Related]
29. Angiopoietins, growth factors, and vascular morphology in early arthritis.
Fearon U; Griosios K; Fraser A; Reece R; Emery P; Jones PF; Veale DJ
J Rheumatol; 2003 Feb; 30(2):260-8. PubMed ID: 12563678
[TBL] [Abstract][Full Text] [Related]
30. Cyclooxygenase-2-derived prostaglandin E2 is involved in vascular endothelial growth factor production in interleukin-1alpha-stimulated human periodontal ligament cells.
Bando Y; Noguchi K; Kobayashi H; Yoshida N; Ishikawa I; Izumi Y
J Periodontal Res; 2009 Jun; 44(3):395-401. PubMed ID: 19210337
[TBL] [Abstract][Full Text] [Related]
31. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.
Zhang L; Yang N; Park JW; Katsaros D; Fracchioli S; Cao G; O'Brien-Jenkins A; Randall TC; Rubin SC; Coukos G
Cancer Res; 2003 Jun; 63(12):3403-12. PubMed ID: 12810677
[TBL] [Abstract][Full Text] [Related]
32. Triptolide inhibits vascular endothelial growth factor expression and production in endothelial cells.
Hu KB; Liu ZH; Guo XH; Liu D; Li LS
Acta Pharmacol Sin; 2001 Jul; 22(7):651-6. PubMed ID: 11749832
[TBL] [Abstract][Full Text] [Related]
33. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
[TBL] [Abstract][Full Text] [Related]
34. Vascular endothelial growth factor inhibits endothelial cell apoptosis induced by tumor necrosis factor-alpha: balance between growth and death signals.
Spyridopoulos I; Brogi E; Kearney M; Sullivan AB; Cetrulo C; Isner JM; Losordo DW
J Mol Cell Cardiol; 1997 May; 29(5):1321-30. PubMed ID: 9201618
[TBL] [Abstract][Full Text] [Related]
35. Vascular endothelial growth factor (VEGF) expression in human prostate cancer: in situ and in vitro expression of VEGF by human prostate cancer cells.
Ferrer FA; Miller LJ; Andrawis RI; Kurtzman SH; Albertsen PC; Laudone VP; Kreutzer DL
J Urol; 1997 Jun; 157(6):2329-33. PubMed ID: 9146665
[TBL] [Abstract][Full Text] [Related]
36. Hypoxia regulates vascular endothelial growth factor receptor KDR/Flk gene expression through adenosine A2 receptors in retinal capillary endothelial cells.
Takagi H; King GL; Ferrara N; Aiello LP
Invest Ophthalmol Vis Sci; 1996 Jun; 37(7):1311-21. PubMed ID: 8641834
[TBL] [Abstract][Full Text] [Related]
37. Production of matrix metalloproteinase-9 in early stage B-CLL: suppression by interferons.
Bauvois B; Dumont J; Mathiot C; Kolb JP
Leukemia; 2002 May; 16(5):791-8. PubMed ID: 11986939
[TBL] [Abstract][Full Text] [Related]
38. The angiogenic peptide vascular endothelial growth factor (VEGF) is expressed in chronic sacral pressure ulcers.
Pufe T; Paulsen F; Petersen W; Mentlein R; Tsokos M
J Pathol; 2003 May; 200(1):130-6. PubMed ID: 12692851
[TBL] [Abstract][Full Text] [Related]
39. Okadaic acid stimulates the expression of vascular endothelial growth factor gene.
Wakiya K; Shibuya M
Biochem Biophys Res Commun; 1999 Nov; 265(2):584-8. PubMed ID: 10558913
[TBL] [Abstract][Full Text] [Related]
40. Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1.
Ryuto M; Ono M; Izumi H; Yoshida S; Weich HA; Kohno K; Kuwano M
J Biol Chem; 1996 Nov; 271(45):28220-8. PubMed ID: 8910439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
